Abstract 1571P
Background
In France, oncology is one of the disciplines for which the percentage of residents reorientating at the start of internship towards another specialty is the highest (8-10%). The determinants of this reorientation are unknown.
Methods
We conducted a quantitative online survey with the 121 interns of the 2022-2023 class during their 1st year of oncology training, with 2 follow-ups over 2 months. 36 potential determinants from previous works (Wright et al. 2004; Beaulieu et al. 2010) were evaluated using a 5-point Likert scale alongside parameters describing the resident. We also assessed their satisfaction with the teaching received. We conducted univariate and multivariate linear regression analyses.
Results
The response rate was 107/121 (88.5%), but 99 questionnaires were usable for the determinants analysis (81.2%). 9 residents were considering or may consider changing speciality. In multivariate analysis, 3 factors were associated with considering a change of specialty: “desire for social commitment” (β=2.15, p=.025), “other experience during the 2 nd -cycle hospital traineeships” (β=3.64, p<.001) and “interest in emergency care” (β=2.13, p=.028). Satisfaction with the education received was negatively associated with the desire to change specialty (β=-3.49, p<.001). The determinants of satisfaction in oncology training were: “being able to move to the desired university” (β=4.24, p=.016), “an image of dynamism of oncology” (β=4.68, p<.001); on the other hand, the “desire for short training” was negatively associated with satisfaction with oncology training (β=0.281, p=.042).
Conclusions
We identified 2 intrinsic factors (social commitment and interest in emergency care) and 2 extrinsic factors (other significant experiences during 2nd-cycles hospital traineeships and low satisfaction in oncology training) as being able to explain the wish of reorientation among oncology residents.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Centre Oscar Lambret.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1501P - Sex-specific variation in symptoms presentation: Experience of an outpatient clinic integrated model between radiotherapy and palliative care
Presenter: Luca Tontini
Session: Poster session 10
1502P - Sexual dysfunction and quality of life in rectal cancer
Presenter: Fatih Kus
Session: Poster session 10
1503P - Spiritual needs in cancer patients: A cross-sectional study
Presenter: Diego Toloi
Session: Poster session 10
1546P - Use of ESMO-MCBS Scorecards in supporting funding decisions in private insurance
Presenter: Samantha Field
Session: Poster session 10
1547P - Time from approval to reimbursement of new cancer and non-cancer drugs: A comparative analysis between the US, England, Germany, and Switzerland (2011-2022)
Presenter: Camille Glaus
Session: Poster session 10
1548P - Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
Presenter: Jacob Reibel
Session: Poster session 10
1549P - Accelerating access to innovative oncology drugs: Insights from France's early access reform
Presenter: Tess Martin
Session: Poster session 10
1550P - Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence
Presenter: Sahar van Waalwijk van Doorn-Khosrovani
Session: Poster session 10
1551P - Breakthrough therapy cancer drugs and indications with FDA approval: Development time, innovation, trials, clinical benefit, epidemiology, and price
Presenter: Christoph Michaeli
Session: Poster session 10
1552P - Regulatory approval of novel immunotherapy for lymphoid neoplasm in the US, EU, and Japan
Presenter: Kensuke Matsuda
Session: Poster session 10